Meridian Bioscience, Inc. Expects to Report Third Quarter Fiscal Year 2018 Operating Results on Tuesday, July 31, 2018
June 28 2018 - 11:00AM
Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading life science
company, expects to release its third quarter fiscal 2018 operating
results before the NASDAQ market opens on Tuesday, July 31, 2018.
The release will be available shortly thereafter on Meridian’s
website at www.meridianbioscience.com.
About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops,
manufactures, markets and distributes a broad range of innovative
diagnostic products. We are dedicated to developing and delivering
better solutions that give answers with speed, accuracy and
simplicity that are redefining the possibilities of life from
discovery to diagnosis. Through discovery and development, we
provide critical life science raw materials used in immunological
and molecular tests for human, animal, plant, and environmental
applications. Through diagnosis, we provide diagnostic solutions in
areas including gastrointestinal and upper respiratory infections
and blood lead level testing. We build relationships and
provide solutions to hospitals, reference laboratories, research
centers, veterinary testing centers, physician offices, diagnostics
manufacturers, and biotech companies in more than 70 countries
around the world.
Meridian’s shares are traded on the NASDAQ Global Select Market,
symbol VIVO. Meridian’s website address is
www.meridianbioscience.com.
Contact:Jack KennyChief Executive
OfficerMeridian Bioscience, Inc.Phone: 513.271.3700Email:
mbi@meridianbioscience.com
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Mar 2023 to Mar 2024